Ali Aminian, MD
The Cleveland Clinic
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ali Aminian, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:38 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07058155 · Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver DiseaseThe Cleveland Clinic · recruiting · Liver Cirrhoses, Portal Hypertension Related to Cirrhosis, Severe Obesity · principal investigator
- Ph4NCT06803888 · Bariatric Surgery vs. Semaglutide vs. TirzepatideAli Aminian · active not recruiting · Obesity and Obesity-related Medical Conditions · principal investigator
- Ph4NCT06374875 · Fibrosis Lessens After Metabolic SurgeryThe Cleveland Clinic · recruiting · Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD), Non-Alcoholic Fatty Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis (MASH) · principal investigator
- N/ANCT04263376 · Bariatric Surgery-Induced Shift in Gut Microbiome and NAFLDThe Cleveland Clinic · completed · Obesity, Diabetes Mellitus, Type 2, NAFLD · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:38 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.